<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04343261</url>
  </required_header>
  <id_info>
    <org_study_id>SFH-20-23</org_study_id>
    <nct_id>NCT04343261</nct_id>
  </id_info>
  <brief_title>Convalescent Plasma in the Treatment of COVID 19</brief_title>
  <official_title>Convalescent Plasma in the Treatment of COVID 19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Saint Francis Care</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Saint Francis Care</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to collect blood from previously COVID-19 infected persons who
      have recovered and use it as a treatment for those who are currently sick with a severe or
      life-threatening COVID-19 infection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to collect blood from previously COVID-19 infected persons who
      have recovered and use it as a treatment for those who are currently sick with a severe or
      life-threatening COVID-19 infection.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">April 10, 2020</start_date>
  <completion_date type="Anticipated">April 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2020</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>28 days</time_frame>
    <description>Mortality within 28 days</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Viral Load</measure>
    <time_frame>7 days</time_frame>
    <description>Reduction of Viral Load ]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum Antibody Titers</measure>
    <time_frame>7 days</time_frame>
    <description>Change in Serum Antibody Titers</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">47</enrollment>
  <condition>SARS-CoV-2</condition>
  <condition>COVID</condition>
  <condition>Coronavirus</condition>
  <arm_group>
    <arm_group_label>COVID-19 patients treated with convalescent plasma</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Severely ill COVID-19 patients treated with convalescent plasma</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Convalescent Plasma</intervention_name>
    <description>treatment with 2 Units of convalescent plasma</description>
    <arm_group_label>COVID-19 patients treated with convalescent plasma</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All genders

          -  Age &gt; 18 yrs and &lt; 90 yrs

          -  Must have laboratory confirmed COVID-19

          -  Must provide informed consent

          -  Must have severe or immediately life-threatening COVID-19,

        Severe disease is defined as:

          -  dyspnea,

          -  respiratory frequency ≥ 30/min,

          -  blood oxygen saturation ≤ 93%,

          -  partial pressure of arterial oxygen to fraction of inspired oxygen ratio &lt; 300

          -  lung infiltrates &gt; 50% within 24 to 48 hours

        Life-threatening disease is defined as:

          -  respiratory failure,

          -  septic shock

          -  multiple organ dysfunction or failure

        Exclusion Criteria:

          -  No gender exclusion

          -  Age &lt; 18 yrs and &gt; 90 yrs

          -  COVID-19 negative
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Latha Dulipsingh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Saint Francis Hospital and Medical Centerr/Trinity Health Of New England</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Trinity Health Of New England</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>April 8, 2020</study_first_submitted>
  <study_first_submitted_qc>April 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 13, 2020</study_first_posted>
  <last_update_submitted>June 16, 2020</last_update_submitted>
  <last_update_submitted_qc>June 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>SARS-CoV-1, COVID, Coronavirus, convalescent plasma, plasma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronavirus Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

